$SRPT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sarepta Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sarepta Therapeutics, Inc.. Get notifications about new insider transactions in Sarepta Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 10 2021 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | M | 42.30 | 5,000 | 211,500 | 0 | |
Mar 10 2021 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Sell | S | 85.76 | 5,000 | 428,800 | 130,517 | 135.5 K to 130.5 K (-3.69 %) |
Mar 10 2021 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Buy | M | 42.30 | 5,000 | 211,500 | 135,517 | 130.5 K to 135.5 K (+3.83 %) |
Mar 10 2021 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | M | 34.92 | 10,000 | 349,200 | 0 | |
Mar 10 2021 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Sell | S | 83.51 | 10,000 | 835,100 | 16,518 | 26.5 K to 16.5 K (-37.71 %) |
Mar 10 2021 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Buy | M | 34.92 | 10,000 | 349,200 | 26,518 | 16.5 K to 26.5 K (+60.54 %) |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | A | 87.11 | 5,518 | 480,673 | 5,518 | |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Grant | A | 0.00 | 2,726 | 0 | 16,518 | 13.8 K to 16.5 K (+19.77 %) |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Rodino-Klapac Louise | Chief Scientific Of ... | Option Exercise | A | 87.11 | 60,000 | 5,226,600 | 60,000 | |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Rodino-Klapac Louise | Chief Scientific Of ... | Grant | A | 0.00 | 15,000 | 0 | 22,169 | 7.2 K to 22.2 K (+209.23 %) |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Option Exercise | A | 87.11 | 60,000 | 5,226,600 | 60,000 | |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Grant | A | 0.00 | 15,000 | 0 | 29,070 | 14.1 K to 29.1 K (+106.61 %) |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Option Exercise | A | 87.11 | 5,518 | 480,673 | 5,518 | |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Grant | A | 0.00 | 2,726 | 0 | 11,852 | 9.1 K to 11.9 K (+29.87 %) |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | MARTIN JOHN C | Director | Option Exercise | A | 87.11 | 5,518 | 480,673 | 5,518 | |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | MARTIN JOHN C | Director | Grant | A | 0.00 | 2,726 | 0 | 7,913 | 5.2 K to 7.9 K (+52.55 %) |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Option Exercise | A | 87.11 | 5,518 | 480,673 | 5,518 | |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Grant | A | 0.00 | 2,726 | 0 | 8,436 | 5.7 K to 8.4 K (+47.74 %) |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Estepan Ian Michael | Chief Financial Off ... | Option Exercise | A | 87.11 | 60,000 | 5,226,600 | 60,000 | |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Estepan Ian Michael | Chief Financial Off ... | Grant | A | 0.00 | 15,000 | 0 | 29,042 | 14 K to 29 K (+106.82 %) |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Ciambrone William | EVP | Option Exercise | A | 87.11 | 60,000 | 5,226,600 | 60,000 | |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Ciambrone William | EVP | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Brown Ryan Edward | SVP, General Counse ... | Option Exercise | A | 87.11 | 60,000 | 5,226,600 | 60,000 | |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Brown Ryan Edward | SVP, General Counse ... | Grant | A | 0.00 | 15,000 | 0 | 19,838 | 4.8 K to 19.8 K (+310.05 %) |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Option Exercise | A | 87.11 | 5,518 | 480,673 | 5,518 | |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Grant | A | 0.00 | 2,726 | 0 | 3,125,366 | 3.1 M to 3.1 M (+0.09 %) |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | A | 87.11 | 5,518 | 480,673 | 5,518 | |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Grant | A | 0.00 | 2,726 | 0 | 130,517 | 127.8 K to 130.5 K (+2.13 %) |
Jan 04 2021 | SRPT | Sarepta Therapeuti ... | INGRAM DOUGLAS S | President & CEO | Payment of Exercise | F | 170.49 | 37,144 | 6,332,681 | 357,868 | 395 K to 357.9 K (-9.40 %) |
Dec 14 2020 | SRPT | Sarepta Therapeuti ... | Rodino-Klapac Louise | Chief Scientific Of ... | Option Exercise | A | 169.54 | 25,000 | 4,238,500 | 25,000 | |
Dec 14 2020 | SRPT | Sarepta Therapeuti ... | Estepan Ian Michael | Chief Financial Off ... | Option Exercise | A | 169.54 | 25,000 | 4,238,500 | 25,000 | |
Dec 14 2020 | SRPT | Sarepta Therapeuti ... | Bratica Joseph | Principal Financial ... | Option Exercise | M | 71.45 | 1,115 | 79,667 | 12,285 | |
Dec 14 2020 | SRPT | Sarepta Therapeuti ... | Bratica Joseph | Principal Financial ... | Sell | S | 165.00 | 1,115 | 183,975 | 8,140 | 9.3 K to 8.1 K (-12.05 %) |
Dec 14 2020 | SRPT | Sarepta Therapeuti ... | Bratica Joseph | Principal Financial ... | Buy | M | 71.45 | 1,115 | 79,667 | 9,255 | 8.1 K to 9.3 K (+13.70 %) |
Dec 10 2020 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Option Exercise | M | 0.00 | 967 | 0 | 967 | |
Dec 10 2020 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Buy | M | 0.00 | 967 | 0 | 5,710 | 4.7 K to 5.7 K (+20.39 %) |
Dec 10 2020 | SRPT | Sarepta Therapeuti ... | Bratica Joseph | Principal Financial ... | Option Exercise | M | 29.60 | 1,125 | 33,300 | 4,500 | |
Dec 10 2020 | SRPT | Sarepta Therapeuti ... | Bratica Joseph | Principal Financial ... | Sell | S | 160.00 | 1,125 | 180,000 | 8,140 | 9.3 K to 8.1 K (-12.14 %) |
Dec 10 2020 | SRPT | Sarepta Therapeuti ... | Bratica Joseph | Principal Financial ... | Buy | M | 29.60 | 1,125 | 33,300 | 9,265 | 8.1 K to 9.3 K (+13.82 %) |
Aug 11 2020 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | M | 34.92 | 10,000 | 349,200 | 10,000 | |
Aug 11 2020 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Sell | S | 159.65 | 777 | 124,048 | 13,792 | 14.6 K to 13.8 K (-5.33 %) |
Aug 11 2020 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Sell | S | 158.95 | 9,223 | 1,465,996 | 14,569 | 23.8 K to 14.6 K (-38.77 %) |
Aug 11 2020 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Buy | M | 34.92 | 10,000 | 349,200 | 23,792 | 13.8 K to 23.8 K (+72.51 %) |
Aug 07 2020 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Sell | S | 159.09 | 3,140 | 499,543 | 3,129,140 | 3.1 M to 3.1 M (-0.10 %) |
Aug 07 2020 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Sell | S | 158.43 | 26,860 | 4,255,430 | 3,132,280 | 3.2 M to 3.1 M (-0.85 %) |
Aug 05 2020 | SRPT | Sarepta Therapeuti ... | Bratica Joseph | Principal Financial ... | Option Exercise | M | 29.60 | 1,125 | 33,300 | 5,625 | |
Aug 05 2020 | SRPT | Sarepta Therapeuti ... | Bratica Joseph | Principal Financial ... | Sell | S | 155.00 | 1,125 | 174,375 | 7,832 | 9 K to 7.8 K (-12.56 %) |
Aug 05 2020 | SRPT | Sarepta Therapeuti ... | Bratica Joseph | Principal Financial ... | Buy | M | 29.60 | 1,125 | 33,300 | 8,957 | 7.8 K to 9 K (+14.36 %) |
Jul 09 2020 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 32.63 | 1,203 | 39,254 | 0 | |
Jul 09 2020 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.71 | 218 | 2,989 | 0 | |
Jul 09 2020 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.71 | 2,385 | 32,698 | 0 | |
Jul 09 2020 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 32.63 | 1,203 | 39,254 | 20,260 | 19.1 K to 20.3 K (+6.31 %) |
Jul 09 2020 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.71 | 218 | 2,989 | 19,057 | 18.8 K to 19.1 K (+1.16 %) |
Jul 09 2020 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.71 | 2,385 | 32,698 | 18,839 | 16.5 K to 18.8 K (+14.49 %) |
Jul 09 2020 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Gift | G | 0.00 | 20,425 | 0 | 16,454 | 36.9 K to 16.5 K (-55.38 %) |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 29.03 | 45,000 | 1,306,350 | 7,708 | |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 29.03 | 45,000 | 1,306,350 | 7,708 | |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 23.85 | 56,984 | 1,359,068 | 0 | |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 23.85 | 56,984 | 1,359,068 | 0 | |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.71 | 1,858 | 25,473 | 0 | |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.71 | 1,858 | 25,473 | 0 | |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.71 | 1,280 | 17,549 | 0 | |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.71 | 1,280 | 17,549 | 0 | |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Sell | S | 171.50 | 55,270 | 9,478,805 | 31,871 | 87.1 K to 31.9 K (-63.43 %) |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Sell | S | 171.50 | 55,270 | 9,478,805 | 31,871 | 87.1 K to 31.9 K (-63.43 %) |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Sell | S | 170.59 | 35,757 | 6,099,787 | 87,141 | 122.9 K to 87.1 K (-29.09 %) |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Sell | S | 170.59 | 35,757 | 6,099,787 | 87,141 | 122.9 K to 87.1 K (-29.09 %) |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Sell | S | 169.56 | 8,086 | 1,371,062 | 122,898 | 131 K to 122.9 K (-6.17 %) |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Sell | S | 169.56 | 8,086 | 1,371,062 | 122,898 | 131 K to 122.9 K (-6.17 %) |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Sell | S | 168.61 | 6,009 | 1,013,177 | 130,984 | 137 K to 131 K (-4.39 %) |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Sell | S | 168.61 | 6,009 | 1,013,177 | 130,984 | 137 K to 131 K (-4.39 %) |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 29.03 | 45,000 | 1,306,350 | 136,993 | 92 K to 137 K (+48.92 %) |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 29.03 | 45,000 | 1,306,350 | 136,993 | 92 K to 137 K (+48.92 %) |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 23.85 | 56,984 | 1,359,068 | 91,993 | 35 K to 92 K (+162.77 %) |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 23.85 | 56,984 | 1,359,068 | 91,993 | 35 K to 92 K (+162.77 %) |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.71 | 1,858 | 25,473 | 35,009 | 33.2 K to 35 K (+5.60 %) |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.71 | 1,858 | 25,473 | 35,009 | 33.2 K to 35 K (+5.60 %) |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.71 | 1,280 | 17,549 | 33,151 | 31.9 K to 33.2 K (+4.02 %) |
Jun 22 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.71 | 1,280 | 17,549 | 33,151 | 31.9 K to 33.2 K (+4.02 %) |
May 22 2020 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | M | 10.08 | 5,000 | 50,400 | 0 | |
May 22 2020 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Sell | S | 151.77 | 854 | 129,612 | 13,792 | 14.6 K to 13.8 K (-5.83 %) |
May 22 2020 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Sell | S | 151.22 | 2,046 | 309,396 | 14,646 | 16.7 K to 14.6 K (-12.26 %) |
May 22 2020 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Sell | S | 149.62 | 2,100 | 314,202 | 16,692 | 18.8 K to 16.7 K (-11.17 %) |
May 22 2020 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Buy | M | 10.08 | 5,000 | 50,400 | 18,792 | 13.8 K to 18.8 K (+36.25 %) |
May 15 2020 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Sell | S | 142.05 | 4,673 | 663,800 | 3,159,140 | 3.2 M to 3.2 M (-0.15 %) |
May 15 2020 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Sell | S | 141.12 | 25,327 | 3,574,146 | 3,163,813 | 3.2 M to 3.2 M (-0.79 %) |
May 15 2020 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Sell | S | 142.05 | 4,673 | 663,800 | 3,159,140 | 3.2 M to 3.2 M (-0.15 %) |
May 15 2020 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Sell | S | 141.12 | 25,327 | 3,574,146 | 3,163,813 | 3.2 M to 3.2 M (-0.79 %) |
Mar 06 2020 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | M | 8.46 | 5,000 | 42,300 | 0 | |
Mar 06 2020 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Sell | S | 116.89 | 5,000 | 584,450 | 13,792 | 18.8 K to 13.8 K (-26.61 %) |
Mar 06 2020 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Buy | M | 8.46 | 5,000 | 42,300 | 18,792 | 13.8 K to 18.8 K (+36.25 %) |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Option Exercise | A | 114.47 | 3,685 | 421,822 | 3,685 | |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Grant | A | 0.00 | 2,075 | 0 | 4,743 | 2.7 K to 4.7 K (+77.77 %) |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | A | 114.47 | 3,685 | 421,822 | 3,685 | |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Grant | A | 0.00 | 2,075 | 0 | 9,126 | 7.1 K to 9.1 K (+29.43 %) |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Option Exercise | A | 114.47 | 3,685 | 421,822 | 3,685 | |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Grant | A | 0.00 | 2,075 | 0 | 9,126 | 7.1 K to 9.1 K (+29.43 %) |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | A | 114.47 | 3,685 | 421,822 | 3,685 | |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Grant | A | 0.00 | 2,075 | 0 | 13,792 | 11.7 K to 13.8 K (+17.71 %) |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Option Exercise | A | 114.47 | 3,685 | 421,822 | 3,685 | |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Grant | A | 0.00 | 2,075 | 0 | 3,189,140 | 3.2 M to 3.2 M (+0.07 %) |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | A | 114.47 | 3,685 | 421,822 | 3,685 | |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Grant | A | 0.00 | 2,075 | 0 | 127,742 | 125.7 K to 127.7 K (+1.65 %) |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | MARTIN JOHN C | Director | Option Exercise | A | 114.47 | 3,685 | 421,822 | 3,685 | |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | MARTIN JOHN C | Director | Option Exercise | A | 114.47 | 5,528 | 632,790 | 5,528 | |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | MARTIN JOHN C | Director | Grant | A | 0.00 | 2,075 | 0 | 5,187 | 3.1 K to 5.2 K (+66.68 %) |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | MARTIN JOHN C | Director | Grant | A | 0.00 | 3,112 | 0 | 3,112 | 0 to 3.1 K |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Option Exercise | A | 114.47 | 37,500 | 4,292,625 | 37,500 | |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Grant | A | 0.00 | 6,700 | 0 | 14,070 | 7.4 K to 14.1 K (+90.91 %) |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Option Exercise | A | 114.47 | 37,500 | 4,292,625 | 37,500 | |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Grant | A | 0.00 | 6,700 | 0 | 8,567 | 1.9 K to 8.6 K (+358.86 %) |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | A | 114.47 | 37,500 | 4,292,625 | 37,500 | |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Grant | A | 0.00 | 6,700 | 0 | 31,871 | 25.2 K to 31.9 K (+26.62 %) |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | A | 114.47 | 37,500 | 4,292,625 | 37,500 | |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Grant | A | 0.00 | 6,700 | 0 | 36,879 | 30.2 K to 36.9 K (+22.20 %) |
Jan 03 2020 | SRPT | Sarepta Therapeuti ... | INGRAM DOUGLAS S | President & CEO | Payment of Exercise | F | 129.04 | 37,185 | 4,798,352 | 395,012 | 432.2 K to 395 K (-8.60 %) |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Option Exercise | M | 26.24 | 26,084 | 684,444 | 20,881 | |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Option Exercise | M | 13.71 | 3,895 | 53,400 | 0 | |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Option Exercise | M | 13.71 | 2,727 | 37,387 | 1,123 | |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Sell | S | 125.50 | 9,294 | 1,166,397 | 1,867 | 11.2 K to 1.9 K (-83.27 %) |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Sell | S | 125.50 | 32,706 | 4,104,603 | 11,161 | 43.9 K to 11.2 K (-74.56 %) |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Buy | M | 26.24 | 26,084 | 684,444 | 43,867 | 17.8 K to 43.9 K (+146.68 %) |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Buy | M | 13.71 | 3,895 | 53,400 | 17,783 | 13.9 K to 17.8 K (+28.05 %) |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Buy | M | 13.71 | 2,727 | 37,387 | 13,888 | 11.2 K to 13.9 K (+24.43 %) |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 23.85 | 59,421 | 1,417,191 | 56,984 | |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.90 | 18,579 | 258,248 | 0 | |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Sell | S | 125.50 | 78,000 | 9,789,000 | 25,171 | 103.2 K to 25.2 K (-75.60 %) |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 23.85 | 59,421 | 1,417,191 | 103,171 | 43.8 K to 103.2 K (+135.82 %) |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.90 | 18,579 | 258,248 | 43,750 | 25.2 K to 43.8 K (+73.81 %) |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 34.92 | 14,723 | 514,127 | 39,277 | |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 32.63 | 21,875 | 713,781 | 10,874 | |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 29.03 | 69,479 | 2,016,975 | 0 | |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 23.85 | 10,466 | 249,614 | 0 | |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.71 | 4,138 | 56,732 | 2,633 | |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.71 | 4,319 | 59,213 | 3,085 | |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Sell | S | 125.50 | 125,000 | 15,687,500 | 30,179 | 155.2 K to 30.2 K (-80.55 %) |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 34.92 | 14,723 | 514,127 | 155,179 | 140.5 K to 155.2 K (+10.48 %) |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 32.63 | 21,875 | 713,781 | 140,456 | 118.6 K to 140.5 K (+18.45 %) |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 29.03 | 69,479 | 2,016,975 | 118,581 | 49.1 K to 118.6 K (+141.50 %) |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 23.85 | 10,466 | 249,614 | 49,102 | 38.6 K to 49.1 K (+27.09 %) |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.71 | 4,138 | 56,732 | 38,636 | 34.5 K to 38.6 K (+11.99 %) |
Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.71 | 4,319 | 59,213 | 34,498 | 30.2 K to 34.5 K (+14.31 %) |
Dec 10 2019 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Option Exercise | M | 0.00 | 967 | 0 | 1,934 | |
Dec 10 2019 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Buy | M | 0.00 | 967 | 0 | 2,668 | 1.7 K to 2.7 K (+56.85 %) |
Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 23.85 | 7,900 | 188,415 | 5,118 | |
Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 23.85 | 7,900 | 188,415 | 5,118 | |
Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.90 | 5,590 | 77,701 | 0 | |
Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.90 | 5,590 | 77,701 | 0 | |
Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.71 | 52 | 713 | 18 | |
Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.71 | 52 | 713 | 18 |